Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis

Leukocyte infiltration and necrosis are two biological phenomena associated with the development of neovascularization during the malignant progression of human astrocytoma. Here, we demonstrate expression of interleukin (IL)-8, a cytokine with chemotactic and angiogenic properties, and of IL-8–binding receptors in astrocytoma. IL-8 expression is first observed in low grade astrocytoma in perivascular tumor areas expressing inflammatory cytokines. In glioblastoma, it further localizes to oxygen-deprived cells surrounding necrosis. Hypoxic/anoxic insults on glioblastoma cells in vitro using anaerobic chamber systems or within spheroids developing central necrosis induced an increase in IL-8 messenger RNA (mRNA) and protein expression. mRNA for IL-8–binding chemokine receptors CXCR1, CXCR2, and the Duffy antigen receptor for chemokines (DARC) were found in all astrocytoma grades by reverse transcription/PCR analysis. In situ hybridization and immunohistochemistry localized DARC expression on normal brain and tumor microvascular cells and CXCR1 and CXCR2 expression to infiltrating leukocytes. These results support a model where IL-8 expression is initiated early in astrocytoma development through induction by inflammatory stimuli and later in tumor progression increases due to reduced microenvironmental oxygen pressure. Augmented IL-8 would directly and/or indirectly promote angiogenesis by binding to DARC and by inducing leukocyte infiltration and activation by binding to CXCR1 and CXCR2.

[1]  Mirna Tenan,et al.  Fas Ligand Expression in Glioblastoma Cell Lines and Primary Astrocytic Brain Tumors , 1997, Brain pathology.

[2]  Erwin G. Van Meir,et al.  Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? , 1997, The Journal of clinical investigation.

[3]  T. Williams,et al.  Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. , 1997, Journal of immunology.

[4]  M. Elkjaer,et al.  Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. , 1997, Blood.

[5]  Mayumi Ono,et al.  Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells , 1996, The Journal of Biological Chemistry.

[6]  B. Premack,et al.  Chemokine receptors: Gateways to inflammation and infection , 1996, Nature Medicine.

[7]  P. Loetscher,et al.  The interleukin‐8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells , 1996, European journal of immunology.

[8]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[9]  W. Cavenee,et al.  Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Kiener,et al.  Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils , 1996, The Journal of experimental medicine.

[11]  M. Burdick,et al.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.

[12]  K. Norrby Interleukin‐8 and de novo mammalian angiogenesis , 1996, Cell proliferation.

[13]  C. Mackay,et al.  Expression of monocyte chemoattractant protein‐1 and interleukin‐8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential , 1996, European journal of immunology.

[14]  A. Wilks,et al.  Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. , 1996, Cancer research.

[15]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[16]  B. Wolff,et al.  Some aspects of IL‐8 pathophysiology III: chemokine interaction with endothelial cells , 1996, Journal of leukocyte biology.

[17]  T. Shono,et al.  Dual Pathways to Tubular Morphogenesis of Vascular Endothelial Cells by Human Glioma Cells: Vascular Endothelial Growth Factor/Basic Fibroblast Growth Factor and Interleukin‐8 , 1995, Japanese journal of cancer research : Gann.

[18]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[19]  K. Plate,et al.  Angiogenesis in malignant gliomas , 1995, Glia.

[20]  Erwin G. Van Meir Cytokines and tumors of the central nervous system , 1995, Glia.

[21]  C. Tournamille,et al.  Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals , 1995, Nature Genetics.

[22]  R. Horuk,et al.  The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor , 1995, The Journal of experimental medicine.

[23]  H. Flad,et al.  IL-8 specifically binds to endothelial but not to smooth muscle cells. , 1995, Journal of immunology.

[24]  R. Ransohoff,et al.  Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. , 1995, Journal of immunology.

[25]  M. Neeman,et al.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Terao,et al.  Inactivation of interleukin‐8 by aminopeptidase N (CD13) , 1995, Journal of leukocyte biology.

[27]  Erwin G. Van Meir,et al.  Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells , 1994, Nature Genetics.

[28]  D. Williams,et al.  Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. , 1994, Journal of immunology.

[29]  D. Danilenko,et al.  Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. , 1994, The Journal of clinical investigation.

[30]  R. Horuk,et al.  Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. , 1994, The Journal of clinical investigation.

[31]  Erwin G. Van Meir,et al.  Human astrocytomas and glioblastomas express monocyte chemoattractant protein‐1 (MCP‐1) in vivo and in vitro , 1994, International journal of cancer.

[32]  C. Bucana,et al.  Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. , 1994, Cancer research.

[33]  J. Kuratsu,et al.  Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. , 1994, Journal of neurosurgery.

[34]  R. Whyte,et al.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.

[35]  D. Pinsky,et al.  Hypoxic induction of interleukin-8 gene expression in human endothelial cells. , 1994, The Journal of clinical investigation.

[36]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[37]  Erwin G. Van Meir,et al.  Analysis of the p53 gene and its expression in human glioblastoma cells. , 1994, Cancer research.

[38]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[39]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[40]  R. Strieter,et al.  Interleukin-8. A corneal factor that induces neovascularization. , 1992, The American journal of pathology.

[41]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[42]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[43]  P. Wilkinson,et al.  Identification of IL-8 as a locomotor attractant for activated human lymphocytes in mononuclear cell cultures with anti-CD3 or purified protein derivative of Mycobacterium tuberculosis. , 1992, Journal of immunology.

[44]  T. Standiford,et al.  Anoxia-hyperoxia induces monocyte-derived interleukin-8. , 1992, The Journal of clinical investigation.

[45]  Erwin G. Van Meir,et al.  Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. , 1992, Cancer research.

[46]  P. Murphy,et al.  Cloning of complementary DNA encoding a functional human interleukin-8 receptor. , 1991, Science.

[47]  W I Wood,et al.  Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.

[48]  K. Kinzler,et al.  Identification of p53 as a sequence-specific DNA-binding protein , 1991, Science.

[49]  Erwin G. Van Meir,et al.  Human glioblastoma cells release interleukin 6 in vivo and in vitro. , 1990, Cancer research.

[50]  M. Hamou,et al.  Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas , 1990, Journal of Neuroimmunology.

[51]  E. Appella,et al.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[52]  E. Leonard,et al.  Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. , 1990, Journal of immunology.

[53]  M. Sticherling,et al.  Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8. , 1989, Journal of immunology.

[54]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[55]  M. Hamou,et al.  Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. , 1988, Cancer research.

[56]  H. Handa,et al.  Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors. , 1986, Neurosurgery.

[57]  R. Sutherland,et al.  A move for the better. , 1994, Environmental health perspectives.

[58]  H. Rodt,et al.  Immunofluorescence study of lymphocytic infiltration in gliomas Identification of T-lymphocytes , 1977, Journal of the Neurological Sciences.

[59]  J. Folkman,et al.  Tumor angiogenesis: a quantitative method for histologic grading. , 1972, Journal of the National Cancer Institute.

[60]  龍頭 正浩 Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells(ヒトグリオーマ細胞における腫瘍壊死因子αによる血管内皮増殖因子の誘導) , 1997 .

[61]  J.-M. Bader Identification of T Lymphocytes , 1997 .

[62]  L. Orci,et al.  Angiogenesis-regulating cytokines: activities and interactions. , 1996, Current topics in microbiology and immunology.

[63]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[64]  W. Pearce,et al.  Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth. , 1994, Pathobiology : journal of immunopathology, molecular and cellular biology.

[65]  E. Brogi,et al.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. , 1994, Circulation.

[66]  K. Bacon,et al.  Characterisation of the in vitro responsiveness of lymphocyte subsets to locomotor stimuli by immunocytochemical methods. , 1991, Journal of immunological methods.

[67]  M. Haine,et al.  Van Damme A. , 1986 .